Archon Capital Management’s NEVRO CORP. NVRO Stock Holding History

Archon Capital Management’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-16,500	Closed	-$928K	–	28
2016 Q1	$928K	Sell	16,500 -43,500	-73%	-$2.57M	0.92%	20
2015 Q4	$4.05M	Buy	60,000 +6,205	+12%	+$332K	2.88%	17
2015 Q3	$2.5M	Buy	+53,795	New	+$2.61M	2.19%	19

Other funds holding NVRO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCI

Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Archon Capital Management's NVRO Position: Q2 2016 in Review

Archon Capital Management sold out of NEVRO CORP. (NVRO) in Q2 2016, closing a stake of 16,500 shares — an estimated $928K sold.

Archon Capital Management first reported a position in NVRO in Q3 2015 and held it in 3 quarters. The position peaked at $4.05M in Q4 2015. 175 funds tracked by Wall St. Rank hold NVRO as of Q2 2016.

Archon Capital Management reported no remaining NEVRO CORP. position as of Q2 2016 after selling out during the quarter.
Archon Capital Management sold 16,500 NEVRO CORP. shares in Q2 2016, an estimated $928K.
Archon Capital Management first reported a position in NEVRO CORP. in Q3 2015 and held it in 3 quarters.
Archon Capital Management's NEVRO CORP. position peaked at $4.05M in Q4 2015.
175 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2016.

Based on Archon Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.